Related Experiment Video
Updated: Aug 26, 2025

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
Cancer and Non-cancer Fatigue Treated With Bupropion: A Systematic Review
Juan Esteban Correa-Morales1, Laura Cuellar-Valencia1, Nidia Mantilla-Manosalva1
1Universidad de La Sabana, (J.E.C.M., L.C.-V., N.M.-M., E.Q.-M., M.F.I.-A., L.F.R.-C.) Bogotá D.C., Colombia; Colombian National Cancer Institute, (J.E.C.M., L.C.-V., N.M.-M.) Bogotá D.C., Colombia.
Bupropion shows promise for treating cancer and non-cancer fatigue, with six of seven studies reporting significant symptom reduction and minimal adverse effects. Further high-quality trials are needed to confirm these findings.
Area of Science:
- Pharmacology
- Oncology
- Internal Medicine
Background:
- Fatigue is a common and debilitating symptom in both cancer and non-cancer conditions, with limited pharmacological treatment options.
- Bupropion, a novel medication, has an unknown efficacy and safety profile for managing fatigue.
Approach:
- A systematic review was conducted by searching PubMed, EMBASE, and Ovid Medline databases up to July 26, 2022.
- Included studies were experimental and quasi-experimental, focusing on adult patients with cancer or non-cancer-related fatigue treated with bupropion and assessed using objective scales.
Key Points:
- Seven studies (N=584) were reviewed, investigating bupropion for cancer-related fatigue (5 studies) and non-cancer fatigue (2 studies).
- Six studies indicated that bupropion significantly reduced fatigue burden without major adverse effects.
- Study heterogeneity in fatigue assessment scales and low study quality necessitate cautious interpretation of results.
Conclusions:
- Bupropion may be an effective and safe option for managing fatigue in both cancer and non-cancer populations.
- Preliminary findings suggest bupropion's potential, but high-quality randomized controlled trials are essential to validate these results.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Cancer Prevention
Some...
Treatment Resistant Cancers
Fatigue

